Exploring the ATR-CHK1 Pathway in the Response of Doxorubicin-induced DNA Damages in Acute Lymphoblastic Leukemia Cells
Andrea Ghelli Luserna di Rorà(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)
Cited by 3
Related Papers
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
|Cell Biology and Toxicology|2021|26
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cells
|Oncology Reports|2020|16